Mingzhao Xing

12PUBLICATIONS
11CO-AUTHORS
Molecular targetsPredictive and prognostic markersImmunogenetics (incl. genetic immunology)Behavioural epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Sep 18, 2024
Efficacy and Safety of Targeted Therapy for Radioiodine-Refractory Differentiated Thyroid Cancer.

Yuqing Zhang, Xiaoxin Zhang, Lifan Lin

|Jul 20, 2024
The genetic duet of concurrent RASAL1 and PTEN alterations promotes cancer aggressiveness by cooperatively activating the PI3K-AKT pathway.

Xiaopei Shen, Jie Tan, Rengyun Liu

|May 12, 2024
Coexisting RET/PTC and TERT Promoter Mutation Predict Poor Prognosis but Effective RET and MEK Targeting in Thyroid Cancer.

Wei Zhang, Shuhuang Lin, Zhuo Wang

|Dec 19, 2023
Genetic trio of BRAF and TERT alterations and rs2853669TT in papillary thyroid cancer aggressiveness.

Rengyun Liu, Guangwu Zhu, Jie Tan

|Dec 08, 2023
Association Between a History of Breast Cancer and Decreased Thyroid Cancer-specific Mortality.

Shuhuang Lin, Zhuo Wang, Mingzhao Xing

|Apr 05, 2023
Hypoxia switches TET1 from being tumor-suppressive to oncogenic.

Qi Yang, Hui Dang, Jiaxin Liu

Pageof 2

Frequent Collaborators

2 joint publications

Jie Tan

2 joint publications

Guangwu Zhu

1 joint publications

Christopher B Umbricht

1 joint publications

Rengyun Liu